Rapport Therapeutics RAPP
NASDAQ RAPP
$25.96 -0.11 (-0.42%)
At close: Nov 10, 2026 · 4:00 PM EST

Rapport Therapeutics (RAPP) Tax Provisions (2023)

Updated

Rapport Therapeutics (RAPP) recorded Tax Provisions of $6,000 in Q4 2023, up 500.0% from the prior quarter.

Analysis

Rapport Therapeutics (RAPP) Tax Provisions (2023) Analysis & Trends

For FY2023, Rapport Therapeutics reported Tax Provisions of $10,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 1.96 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -176.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 609.00 Mn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 492.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.01 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 291.00 Mn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 822.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 634.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 134.00 Mn
10 Rapport Therapeutics 1.27 Bn 876.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 6,000.00
Sep 30, 2023 1,000.00
Jun 30, 2023 2,000.00
API Access

Rapport Therapeutics Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=RAPP&period=max&api_key=YOUR_API_KEY